genprowebdirectory
GEN Edge
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Webinars/Virtual Events
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Latest News
Login
Subscribe
News
Artificial Intelligence
Burst of Protein Structure Predictions from DeepMind, EMBL
Microbiome
Engineered Bacterial Therapeutics Get Boost from PKU Study Data
Biomarkers
Biomarkers Found Related to Most Common Type of Leukemia
Nanotechnology
Nanomaterial Dimmer Switch Modulates Brain and Heart Cell Activity Using Near…
Eye Disorders
Gene Therapy Protects Optic Nerve Cells and Vision in Mice with…
Insights
All
Trends for 2020
Trends for 2021
Bioprocessing
Microsaic Systems Goes Real-Time with PAT
Bioprocessing
Know-How and Modeling Keys to Better Bioprocessing
Bioprocessing
Real-time Tools for Rapid Biomanufacturing Quality Control
Immunology
Multiomics Clinical Trial Compares Fermented and High-Fiber Diets
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 Synthetic Biology Companies
A-Lists
Seven Up-and-Coming COVID-19 Drugs
A-Lists
Top 8 Best-Selling COVID-19 Vaccines and Drugs of Q1 2021
A-Lists
Top 10 Life Sciences Jobs Most in Demand over the Next…
A-Lists
Top 10 U.S. Biopharma Clusters
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Webinars/Virtual Events
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Antibodies
Antibody Drug Conjugates
Antibody Drug Conjugates
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Antibody Drug Conjugates
Mersana Lives in a QbD World
Antibody Drug Conjugates
Cell and Gene Therapies and ADCs Driving Tech Innovation
Antibody Drug Conjugates
Unique ADC Strategy Targets Leukemia
Antibody Drug Conjugates
RNA in Its DNA: Avidity Biosciences Combines mAb Selectivity, Oligonucleotide Precision
Antibody Drug Conjugates
Antibody-Drug Combination Regresses Pancreatic Tumor in Mice
Antibody Drug Conjugates
Merck & Co. to Acquire VelosBio for $2.75B, Expanding Cancer Pipeline
Antibody Drug Conjugates
Merck & Co. Commits Up to $4.2B toward Seattle Genetics Cancer...
Antibody Drug Conjugates
Gilead to Acquire Immunomedics for $21B, Adding Breast Cancer ADC to...
Antibody Drug Conjugates
MilliporeSigma Plans $65 Million Manufacturing Expansion
Antibody Drug Conjugates
AstraZeneca, Daiichi Sankyo Target TROP2 in Up-to-$6B Cancer Collaboration
Commentary
Overcoming Challenges in the Development of Anticancer ADCs
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
Antibody Drug Conjugates
Recent Advances and the Future of Antibody Engineering
Antibody Drug Conjugates
AstraZeneca, Daiichi Sankyo Launch Potentially $6.9B+ Collaboration to Develop Cancer ADC
Webinars
The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates
1
2
3
...
11
Page 1 of 11
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
